Search
Neumora Therapeutics Inc
NMRAAdd to Watchlist
1.670USD
+0.050+3.09%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
304.20MMarket Cap
LossP/E TTM
Neumora Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.45
5.20%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its current assets were 190.54M, with a year-on-year change of -39.33.
What are the total assets of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its total assets of Neumora Therapeutics Inc were 191.05M, with a year-on-year change of -39.73.
What are the total liabilities of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its total liabilities of Neumora Therapeutics Inc were 87.18M, with a year-on-year change of 191.48.
What is the total equity of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its total equity of Neumora Therapeutics Inc was 103.87M, with a year-on-year change of -63.82.
What is the net investment of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its net investment of Neumora Therapeutics Inc was 168.52M, with a year-on-year change of 338.84.
What is the net financing of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its net financing of Neumora Therapeutics Inc was 77.09M, with a year-on-year change of 256.84.
What is the Earnings Per Share (EPS) of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.45, with a year-on-year change of 5.20.
What is the Return on Equity (ROE) of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -121.21, with a year-on-year change of -87.98.
What is the Return on Assets (ROA) of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -93.28, with a year-on-year change of -55.56.
What is the operating profit of Neumora Therapeutics Inc?
According to Neumora Therapeutics Inc's FY2025 earnings report, its operating profit was -236.16M, with a year-on-year change of 10.36.